Natera Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 8.08
Dividend & YieldN/A$ (N/A)
Beta 1.33
Market capitalization 4.05B
Operating cash flow -449.11M
ESG Scores unknown

Company description

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.

Sector: Healthcare - Industry: Diagnostics & Research

Financial Ratios
Quick Ratio4.87
Working Capital-0.54
Return On Equity-0.72
Debt To Equity0.43
Fixed Asset Ratio0
Fixed Interest Cover-56.37

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 46.55M 34.59M -7.01M -24.99M
Total Cashflows From Investing Activities -5.16M -266.35M -331.46M -205.19M
Net Borrowings 199.56M 199.56M 199.56M
Total Cash From Financing Activities 113.72M 340.77M 500.85M 576.19M
Change To Operating Activities 3.6M -10.72M 1.19M 29.77M
Issuance Of Stock 113.72M 340.77M 301.29M 576.19M
Net Income -128.15M -124.83M -229.74M -471.72M
Change In Cash 37.98M 10.98M -13.13M 35.76M
Effect Of Exchange Rate
Total Cash From Operating Activities -70.58M -63.44M -182.51M -335.24M
Depreciation 6.2M 6.53M 7.61M 10.15M
Change To Account Receivables -18.09M 2.42M -25.83M -43.35M
Other Cashflows From Financing Activities
Change To Netincome 22.52M 26M 77.6M 170.07M
Capital Expenditures -3.88M -4.97M -19.6M -49.59M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 51.35M 51.36M 100.03M 264.21M
Income Before Tax -127.83M -122.83M -229.65M -471.1M
Net Income -128.15M -124.83M -229.74M -471.72M
Selling General Administrative 154.87M 204.41M 303.63M 511.03M
Gross Profit 91.6M 126.86M 187.38M 307.07M
Ebit -114.63M -128.9M -216.28M -468.17M
Operating Income -114.63M -128.9M -216.28M -468.17M
Interest Expense -10.48M -10.69M -15.08M -8.3M
Income Tax Expense 321k 2M 98k 618k
Total Revenue 257.65M 302.33M 391M 625.49M
Cost Of Revenue 166.06M 175.47M 203.62M 318.42M
Total Other Income ExpenseNet -13.21M 6.08M -13.37M -2.92M
Net Income From Continuing Ops -128.15M -124.83M -229.74M -471.72M
Net Income Applicable To Common Shares -128.15M -124.83M -229.74M -471.72M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 236.01M 303.94M 445.92M 583.18M
Total Stockholder Equity 32.16M 278.71M 486.24M 653.3M
Other Current Liabilities 15.52M 66.91M 69.18M 26.47M
Total Assets 268.17M 582.66M 932.15M 1.24B
Common Stock 7k 8k 9k 10k
Other Current Assets 4.6M 55k 187k 228k
Retained Earnings -574.53M -699.17M -929.32M -1.39B
Treasury Stock -552k 919k 4.26M -2.29M
Cash 46.41M 61.93M 48.67M 84.39M
Total Current Liabilities 113.98M 179.87M 199.05M 218.96M
Other Stockholder Equity -552k 919k 4.26M -2.29M
Property, Plant, and Equipment 22.64M 45.81M 53.05M 122.23M
Total Current Assets 240.52M 523.17M 862.66M 1.09B
Net Tangible Assets 30.46M 277.51M 484.54M 651M
Net Receivables 62.22M 53.35M 78.56M 122.07M
Accounts Payable 17.33M 12.9M 10.82M 31M


Insider Transactions

Here are the insider transactions of stock shares related to Natera Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SCHUEREN ROBERT ALANSale at price 42.41 per share.D2022-10-24Chief Operating Officer3.13k
SHEENA JONATHANSale at price 42.41 per share.D2022-10-24Director44
BROPHY MICHAEL BURKESSale at price 42.41 per share.D2022-10-24Chief Financial Officer2.49k
CHAPMAN STEVEN LEONARDSale at price 42.41 per share.D2022-10-24Chief Executive Officer905
RABINOWITZ DANIEL ASale at price 42.41 per share.D2022-10-24Officer350
SCHUEREN ROBERT ALAND2022-10-21Chief Operating Officer6.14k
SHEENA JONATHAND2022-10-21Director143
BROPHY MICHAEL BURKESD2022-10-21Chief Financial Officer6.14k
CHAPMAN STEVEN LEONARDD2022-10-21Chief Executive Officer1.77k
RABINOWITZ DANIEL AD2022-10-21Officer644
SCHUEREN ROBERT ALANConversion of Exercise of derivative security at price 13.01 per share.D2022-10-18Chief Operating Officer1.92k
ROSENMAN HERMANStock Award(Grant) at price 45.42 per share.D2022-10-14Director399
HEALY JAMES IStock Award(Grant) at price 45.42 per share.D2022-10-14Director344
BAYNES ROY DStock Award(Grant) at price 45.42 per share.D2022-10-14Director275
MARCUS GAIL BOXERStock Award(Grant) at price 45.42 per share.D2022-10-14Director178
CHAPMAN ROWAN EStock Award(Grant) at price 45.42 per share.D2022-10-14Director330
SCHUEREN ROBERT ALANSale at price 42.12 per share.D2022-10-10Chief Operating Officer2.01k
SCHUEREN ROBERT ALAND2022-10-07Chief Operating Officer3.98k
CHAPMAN STEVEN LEONARDSale at price 44.43 per share.D2022-10-03Chief Executive Officer1.56k
CHAPMAN STEVEN LEONARDD2022-09-30Chief Executive Officer3.12k
SCHUEREN ROBERT ALANSale at price 44.04 per share.D2022-09-28Chief Operating Officer1.38k
BROPHY MICHAEL BURKESSale at price 44.04 per share.D2022-09-28Chief Financial Officer915
CHAPMAN STEVEN LEONARDSale at price 44.04 per share.D2022-09-28Chief Executive Officer2.61k
RABINOWITZ DANIEL ASale at price 44.04 per share.D2022-09-28Officer729
SCHUEREN ROBERT ALAND2022-09-27Chief Operating Officer2.75k
SHEENA JONATHAND2022-09-27Director447
BROPHY MICHAEL BURKESD2022-09-27Chief Financial Officer2.29k
CHAPMAN STEVEN LEONARDD2022-09-27Chief Executive Officer5.18k
RABINOWITZ DANIEL AD2022-09-27Officer1.36k
BROPHY MICHAEL BURKESSale at price 45.30 per share.D2022-09-23Chief Financial Officer433
CHAPMAN STEVEN LEONARDSale at price 45.30 per share.D2022-09-23Chief Executive Officer1.67k
RABINOWITZ DANIEL ASale at price 45.30 per share.D2022-09-23Officer481
RABINOWITZ MATTHEWD2022-09-22Officer and Director400
SHEENA JONATHAND2022-09-22Director455
BROPHY MICHAEL BURKESD2022-09-22Chief Financial Officer1.08k
CHAPMAN STEVEN LEONARDD2022-09-22Chief Executive Officer3.31k
RABINOWITZ DANIEL AD2022-09-22Officer893
SCHUEREN ROBERT ALANSale at price 46.26 per share.D2022-07-22Chief Operating Officer572
BROPHY MICHAEL BURKESSale at price 46.26 per share.D2022-07-22Chief Financial Officer454
CHAPMAN STEVEN LEONARDSale at price 46.26 per share.D2022-07-22Chief Executive Officer886
RABINOWITZ DANIEL ASale at price 46.26 per share.D2022-07-22Officer342
SCHUEREN ROBERT ALANStock Award(Grant) at price 0.00 per share.D2022-07-21Chief Operating Officer1.14k
SCHUEREN ROBERT ALANConversion of Exercise of derivative security at price 46.50 per share.D2022-07-21Chief Operating Officer1.14k
SHEENA JONATHAND2022-07-21Director143
BROPHY MICHAEL BURKESD2022-07-21Chief Financial Officer1.15k
CHAPMAN STEVEN LEONARDD2022-07-21Chief Executive Officer1.77k
RABINOWITZ DANIEL AD2022-07-21Officer644
SCHUEREN ROBERT ALANConversion of Exercise of derivative security at price 13.01 per share.D2022-07-20Chief Operating Officer1.28k
ROSENMAN HERMANStock Award(Grant) at price 0.00 per share.D2022-07-08Director499
HEALY JAMES IStock Award(Grant) at price 0.00 per share.D2022-07-08Director430
SCHUEREN ROBERT ALANSale at price 39.51 per share.D2022-07-08Chief Operating Officer2.02k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Natera Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Natera Inc

Here is the result of two systematic investment strategies applied to Natera Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Natera Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Natera Inc:

Natera Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 329.44% on the backtest period.

Performance at glance

Performance

329.44 %

Latent gain

7611.59 $

Invested capital

2310.49 $

Annualized return

79.57 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Natera Inc

This is the result of two momentum investment strategies applied to Natera Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Natera Inc

The following chart shows all the entries opened by the momentum investment system on Natera Inc:

Natera Inc momentum entries
  • The first momentum investment strategy would give 432.86% of return on Natera Inc. That represents 14872.68$ of latent gain with 3435.92$ of employed capital.
  • The second momentum investment strategy would give 433.73% of return on Natera Inc. That represents 6431.26$ of latent gain with 1482.79$ of employed capital.
Performance at glance (1Q Momentum)

Performance

432.86 %

Latent gain

14872.68 $

Invested capital

3435.92 $

Annualized return

12.5 %
Performance at glance (2Q Momentum)

Performance

433.73 %

Latent gain

6431.26 $

Invested capital

1482.79 $

Annualized return

118.51 %

Momentum equity curve on Natera Inc

The following chart shows the equity curve of the two momentum strategies applied to Natera Inc:

Natera Inc momentum equity

Note: the dividends potentially given by Natera Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Natera Inc

The following chart shows the employed capital evolution of the two momentum strategies on Natera Inc since the beginning:

Natera Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Natera Inc

Buy the dip entry openings on Natera Inc

Natera Inc

The performance achieved by the robo-advisor on Natera Inc is 26.75%. That represents 74.79$ of latent gain with 279.57$ of employed capital. The following chart shows Natera Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Natera Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

26.75 %

Latent gain

74.79 $

Invested capital

279.57 $

Annualized return

12.5 %

Equity curve of the strategy applied to Natera Inc

The following chart shows the result of the investment strategy applied to Natera Inc:

Natera Inc

Note: the dividends potentially given by Natera Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Natera Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Natera Inc:

Natera Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Natera Inc

In this section, I will compare the three previous investment strategies applied to Natera Inc.

Equity curve comparison on Natera Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Natera Inc investment strategy comparison

Employed capital comparison on Natera Inc

Natera Inc investment comparison

Performance comparison on Natera Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 329.44% 7611.59$ 2310.49$ 79.57%
Momentum 1 quarter 432.86% 14872.68$ 3435.92$ 110.99%
Momentum 2 quarters 433.73% 6431.26$ 1482.79$ 118.51%
Non-directional 26.75% 74.79$ 279.57$ 12.5%
Annualized return comparison

Automatic investment

79.57 %

Momentum 1Q

118.51 %

Momentum 2Q

118.51 %

Non-directional

12.5 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Natera Inc:

Positive correlations

Most correlated stocks this year

  • Natera Inc

  • Most correlated stocks last 3 months

  • Natera Inc

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • GDC

  • Note: The algorithm computes the probability of correlation between Natera Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Natera Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Natera Inc
    Country United States
    City San Carlos
    Address 13011 McCallen Pass Building A
    Phone 650 249 9090
    Website www.natera.com
    FullTime employees 2670
    Industry Diagnostics & Research
    Sector Healthcare
    Exchange XNAS
    Ticker NTRA
    Market www.nasdaq.com

    Natera Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown